Myasthenia gravis (MG) is a uncommon neuromuscular disease characterized by bodily weakness and exhaustion. The disease occurs when the connection between the brain and muscle tissue is impaired . This breakdown is typically due to the body's defenses attacking the junction where nerve fibers and

Biktarvy functions as a groundbreaking medication designed to controlling HIV. This powerful combination therapy combines : emtricitabine, rilpivirine, and bictegravir. These components work synergistically to reduce the replication of the HIV virus, thereby slowing disease progression. For many